These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 24816841)
1. Overexpression of LAPTM4B is correlated with tumor angiogenesis and poor prognosis in non-small cell lung cancer. Tang H; Tian H; Yue W; Li L; Li S; Gao C; Si L; Qi L; Lu M Med Oncol; 2014 Jun; 31(6):974. PubMed ID: 24816841 [TBL] [Abstract][Full Text] [Related]
2. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer. Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of Nuclear Heat Shock Factor 1 Contributes to Tumor Angiogenesis and Poor Survival in Patients With Non-Small Cell Lung Cancer. Cui J; Tian H; Chen G Ann Thorac Surg; 2015 Aug; 100(2):465-72. PubMed ID: 26095102 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of LAPTM4B: an independent prognostic marker in breast cancer. Xiao M; Jia S; Wang H; Wang J; Huang Y; Li Z J Cancer Res Clin Oncol; 2013 Apr; 139(4):661-7. PubMed ID: 23292099 [TBL] [Abstract][Full Text] [Related]
5. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma. Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of metastasis-associated protein 1 is significantly correlated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer. Li SH; Tian H; Yue WM; Li L; Li WJ; Chen ZT; Hu WS; Zhu YC; Qi L Ann Surg Oncol; 2011 Jul; 18(7):2048-56. PubMed ID: 21290196 [TBL] [Abstract][Full Text] [Related]
7. Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer. Meng F; Tan S; Liu T; Song H; Lou G Tumour Biol; 2016 Apr; 37(4):4849-55. PubMed ID: 26526574 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer. Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626 [TBL] [Abstract][Full Text] [Related]
9. Astrocyte elevated gene-1 is overexpressed in non-small-cell lung cancer and associated with increased tumour angiogenesis. Ding Q; Chen Y; Dong S; Xu X; Liu J; Song P; Yu C; Ma Z Interact Cardiovasc Thorac Surg; 2018 Mar; 26(3):395-401. PubMed ID: 29049797 [TBL] [Abstract][Full Text] [Related]
10. Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer. Qiao M; Hu G Tumour Biol; 2015 Sep; 36(10):7493-9. PubMed ID: 25910706 [TBL] [Abstract][Full Text] [Related]
11. Decreased tumstatin-mRNA is associated with poor outcome in patients with NSCLC. Luo YQ; Ming Z; Zhao L; Yao LJ; Dong H; Du JP; Wu SZ; Hu W IUBMB Life; 2012 May; 64(5):423-31. PubMed ID: 22473740 [TBL] [Abstract][Full Text] [Related]
12. Lysosomal-associated protein transmembrane 4 Beta-35 overexpression is a novel independent prognostic marker for gastric carcinoma. Liu L; Xu X; Jing L; Zhou G; Cao Z; Han Y; Zhou R PLoS One; 2015; 10(2):e0118026. PubMed ID: 25689860 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer. Zhang H; Wei Q; Liu R; Qi S; Liang P; Qi C; Wang A; Sheng B; Li L; Xu Y PLoS One; 2014; 9(3):e91069. PubMed ID: 24651764 [TBL] [Abstract][Full Text] [Related]
14. Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients. Li S; Wang L; Meng Y; Chang Y; Xu J; Zhang Q Oncotarget; 2017 Jun; 8(25):41282-41293. PubMed ID: 28476037 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of LAPTM4B-35 in cervical carcinoma: a clinicopathologic study. Meng F; Luo C; Hu Y; Yin M; Lin M; Lou G; Zhou R Int J Gynecol Pathol; 2010 Nov; 29(6):587-93. PubMed ID: 20881850 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis. Takanami I Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511 [TBL] [Abstract][Full Text] [Related]
17. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients. Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595 [TBL] [Abstract][Full Text] [Related]
18. LAPTM4B overexpression is a novel independent prognostic marker for metastatic ovarian tumors. Yin M; Lou C; Zhang W; Meng F; Zhang H; Ning X; Zhou R; Dong X; Lou G Int J Gynecol Cancer; 2012 Jan; 22(1):54-62. PubMed ID: 22193644 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis. Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer. Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]